Clinical trial
Glycine and D-Cycloserine in Schizophrenia
NCT00000372 · Massachusetts General Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00000372 |
|---|---|
| Title | Glycine and D-Cycloserine in Schizophrenia |
| Official title | A Placebo Controlled Trial of Glycine Added to Clozapine in Schizophrenia |
| Lead sponsor | Massachusetts General Hospital, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Schizophrenia |
| Intervention type | Drug |
| Interventions | D-cycloserine, Glycine, Clozapine, Placebo |
| Enrollment | 0 |
| Start date | Mar 1, 1998 |
| Primary completion | Nov 1, 2005 |
| Completion | Nov 1, 2005 |
| First posted | Nov 3, 1999 |
| Last update posted | Jun 12, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: